Galvani Bioelectronics announced that it expelled from its board of directors the expert Moncef Al-Salawi, who headed the anti-Corona vaccine development team under the administration of former US President Donald Trump.
And Galvani Bioelectronics, a partnership between Google Spinoff Verily and pharmaceutical giant GlaxoSmithKline (GSK), has reported that El-Slawi was fired following allegations of his involvement in sexual harassment.
The company said in a statement, today, Wednesday, that the decision to expel Al-Salawi came after GSK received a letter containing “allegations of sexual harassment and inappropriate behavior, which occurred years ago towards an employee of the company by Dr. Al-Salawi.”
“Immediately upon receiving the letter, the GSK Board of Directors immediately launched an investigation with an experienced law firm, and the investigation has proven the allegations of harassment,” she added.
The company added that Al-Sallawi’s behavior “is totally unacceptable, and represents an abuse of his leadership position, and violates company policies and conflicts with the strong values that define GSK’s culture.”
Al-Sallawi was born in Morocco and lives in the United States, and was appointed by the Trump administration as part of the so-called “Warp Speed” process to accelerate efforts to develop a vaccine against the emerging corona virus.
Source: The Hill